Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Edelmann

Showing results (141-150 of 218) with videos related to

Pageof 22
Sort By:
ESC Heart Failure|August 30, 2020
Incremental prognostic value of a novel metabolite-based biomarker score in congestive heart failure patientsPeter McGranaghan, Hans-Dirk Düngen, Anshul Saxena, et al.
JAMA Cardiology|November 13, 2020
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA TrialCarolyn S P Lam, Anna Giczewska, Karen Sliwa, et al.
JACC. Heart Failure|December 20, 2015
Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD TrialFrank Edelmann, Lindy Musial-Bright, Goetz Gelbrich, et al.
European Journal of Heart Failure|September 12, 2017
Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial)Tobias Daniel Trippel, Sophie Van Linthout, Dirk Westermann, et al.
European Heart Journal. Cardiovascular Imaging|November 20, 2019
Potential usefulness and clinical relevance of a novel left atrial filling index to estimate left ventricular filling pressures in patients with preserved left ventricular ejection fractionKerstin Braunauer, Hans-Dirk Düngen, Evgeny Belyavskiy, et al.
European Journal of Heart Failure|October 28, 2022
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trialsJoão Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
JAMA|July 2, 2016
Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical TrialChristiane E Angermann, Götz Gelbrich, Stefan Störk, et al.
Scientific Reports|July 6, 2024
Reduced dynamic changes in pulmonary artery compliance during isometric handgrip exercise in patients with heart failureDjawid Hashemi, Xuewen Hou, Patrick Doeblin, et al.
Biology of Sex Differences|June 16, 2026
Circulating nitric oxide pathway metabolites in heart failure with preserved ejection fraction: a sex-stratified cross-sectional analysisSophia Marie-Theres Dinges, Edzard Schwedhelm, Flavia Baldassarri, et al.
International Journal of Cardiology|February 4, 2023
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trialsJoão Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
Pageof 22

Showing results (141-150 of 218) with videos related to

Sort By:
Pageof 22
ESC Heart Failure|August 30, 2020
Incremental prognostic value of a novel metabolite-based biomarker score in congestive heart failure patientsPeter McGranaghan, Hans-Dirk Düngen, Anshul Saxena, et al.
JAMA Cardiology|November 13, 2020
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA TrialCarolyn S P Lam, Anna Giczewska, Karen Sliwa, et al.
JACC. Heart Failure|December 20, 2015
Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD TrialFrank Edelmann, Lindy Musial-Bright, Goetz Gelbrich, et al.
European Journal of Heart Failure|September 12, 2017
Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial)Tobias Daniel Trippel, Sophie Van Linthout, Dirk Westermann, et al.
European Heart Journal. Cardiovascular Imaging|November 20, 2019
Potential usefulness and clinical relevance of a novel left atrial filling index to estimate left ventricular filling pressures in patients with preserved left ventricular ejection fractionKerstin Braunauer, Hans-Dirk Düngen, Evgeny Belyavskiy, et al.
European Journal of Heart Failure|October 28, 2022
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trialsJoão Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
JAMA|July 2, 2016
Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical TrialChristiane E Angermann, Götz Gelbrich, Stefan Störk, et al.
Scientific Reports|July 6, 2024
Reduced dynamic changes in pulmonary artery compliance during isometric handgrip exercise in patients with heart failureDjawid Hashemi, Xuewen Hou, Patrick Doeblin, et al.
Biology of Sex Differences|June 16, 2026
Circulating nitric oxide pathway metabolites in heart failure with preserved ejection fraction: a sex-stratified cross-sectional analysisSophia Marie-Theres Dinges, Edzard Schwedhelm, Flavia Baldassarri, et al.
International Journal of Cardiology|February 4, 2023
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trialsJoão Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
Pageof 22